HIC
SNY icon

Hamrick Investment Counsel’s Sanofi SNY Stock Holding History

Hamrick Investment Counsel’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7K Hold
450
– – 0.01% 196
2025
Q4 		$21.8K Buy
+450
New +$22.3K 0.02% 111

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Hamrick Investment Counsel's SNY Position: Q1 2026 in Review

Hamrick Investment Counsel held its Sanofi (SNY) position steady in Q1 2026 at 450 shares worth $21.7K. The position accounts for 0.01% of the portfolio, ranked #196.

Hamrick Investment Counsel first reported a position in SNY in Q4 2025 and has held it in 2 quarters since. The position peaked at $21.8K in Q4 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Hamrick Investment Counsel held 450 shares of Sanofi worth $21.7K as of Q1 2026.
  • Hamrick Investment Counsel left its Sanofi share count unchanged in Q1 2026.
  • Sanofi made up 0.01% of Hamrick Investment Counsel's portfolio in Q1 2026, its #196 holding.
  • Hamrick Investment Counsel first reported a position in Sanofi in Q4 2025 and has held it in 2 quarters since.
  • Hamrick Investment Counsel's Sanofi position peaked at $21.8K in Q4 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Hamrick Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.